参考文献/References:
[1] Wang Y, Morrow JS. Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues[J]. J Biol Chem, 2000, 275(11): 8062-8071.
[2] Reifschneider NH, Goto S, Nakamoto H, et al. Defining the mitochondrial proteomes from five rat organs in a physiologically significant context using 2D blue-native/SDS-PAGE[J]. J Proteome Res, 2006, 5(5): 1117-1132.
[3] Siegel RD. Naishadham and A. Jemal[J]. Cancer statistics 2013, CA Cancer J Clin, 2013, 63(1): 11-30.
[4]顾方六 .我国良性前列腺增生和前列腺癌发病调查 [J].北京医科大学学报, 2000, 32(1): 30-33.
[5] Peyromaure M, Debré B, Mao K, et al. Management of prostate cancer in China: a multicenter report of 6 institutions[J]. J Urol, 2005, 174(5): 1794-1797.
[6] Pang J, Liu WP, Liu XP, et al. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis[J]. J Proteome Res, 2010, 9(1): 216-226.
[7]张立勇 ,丁芳 ,刘仲敏 ,等, SLP-2基因反义核酸对食管鳞癌细胞系 TE12生长和增殖的影响[J].癌症, 2005, 24(2): 155-159.
[8] Wang Y, Cao W, Yu Z, et al. Downregulation of a mitochondria associated protein SLP-2 inhibits tumor cell motility, proliferation and enhances cell sensitivity to chemotherapeutic reagents [J]. Cancer Biol Ther, 2009, 8(17): 1651-1658.
[9] Song L, Liu L, Wu Z, et al. Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-kappaB/MMP-9 pathway[J]. J Pathol, 2012, 226(3): 534-543.
[10] Cao W, Zhang B, Li J, et al. SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer[J]. Pathology, 2011, 43(7): 713-718.
[11] Chang D, Ma K, Gong M, et al. SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma[J]. Biomarkers, 2010, 15(2): 104-110.
相似文献/References:
[1]周建华,高新,蔡育彬,等.腹腔镜前列腺癌根治术126例3年随访结果[J].中华腔镜泌尿外科杂志(电子版),2007,(01):22.
ZHOU Jian-hua,GAO Xin,CAI Yu-bin,et al.Results of study of 126 cases underwent laparoscopic radical Prostatectomy during three years' follow-up[J].,2007,(01):22.
[2]关健强,周少丽,龚楚链,等.腹腔镜下前列腺癌根治术中呼气末CO2分压的变化及意义[J].中华腔镜泌尿外科杂志(电子版),2008,(03):37.
GUAN Jian-qiang,ZHOU Shao-li,GONG Chu-lian,et al.Difference between arterial and end-tidal carbon dioxide pressures in laparoscopic radical prostarectome[J].,2008,(01):37.
[3]乔鹏,邢念增.经腹膜外腹腔镜前列腺癌根治术(附9例报告)[J].中华腔镜泌尿外科杂志(电子版),2009,(01):25.
QIAO Peng,XING Nian-zeng.Extraperitoneal laparoscopic radical prostatectomy: a report of 9 cases[J].,2009,(01):25.
[4]进展,孙其鹏,高新.TMPRSS2-ETS融合基因在前列腺癌研究的进展[J].中华腔镜泌尿外科杂志(电子版),2009,(04):354.
[5]黄海,杜涛,黄健,等.高效抑制核因子κ-B的茎环RNA基因序列的获得[J].中华腔镜泌尿外科杂志(电子版),2009,(05):444.
[6]高新,邱剑光,周祥福,等.腹腔镜前列腺癌根治术5年随访结果——中国单中心170例报道[J].中华腔镜泌尿外科杂志(电子版),2010,(01):2.
GAO Xin,QIU Jian-guang,ZHOU Xiang-fu,et al.Laparoscopic radical prostatectomy:oncological and functional results of 170 patients with a minimum 5-year follow-up[J].,2010,(01):2.
[7]刘伟鹏,庞俊,李辽源,等.前列腺癌CRMP4基因启动子甲基化研究[J].中华腔镜泌尿外科杂志(电子版),2010,(01):57.
LIU Wei-peng,PANG Jun,LI Liao-yuan,et al.A study on promoter methylation of CRMP4 in prostate cancer[J].,2010,(01):57.
[8]孙其鹏,庞俊,李辽源,等.荧光原位杂交技术在前列腺癌诊断中的临床应用[J].中华腔镜泌尿外科杂志(电子版),2010,(01):64.
SUN Qi-peng,PANG Jun,LI Liao-yuan,et al.Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the diagnosis of prostate cancer[J].,2010,(01):64.
[9]蒲小勇,陆敏华,高新,等.不同穿刺针数经直肠前列腺穿刺活检诊断前列腺癌的研究[J].中华腔镜泌尿外科杂志(电子版),2010,(05):347.
PU Xiao-yong,LU Ming-hua,GAO Xin,et al.Comparative study of the different cores using transrectal prostate biopsy in diagnosis of prostate cancer[J].,2010,(01):347.
[10]刘小彭,高新,周祥福,等.耻骨后前列腺癌根治术联合内分泌治疗T3N1期前列腺癌[J].中华腔镜泌尿外科杂志(电子版),2010,(05):374.
LIU Xiao-peng,GAO Xin,ZHOU Xiang-fu,et al.Radical prostatectomy combining with adjuvant hormone therapy for treatment of prostate cancer with pelvic lymph node metastasis[J].,2010,(01):374.